314 related articles for article (PubMed ID: 36142934)
21. Challenging the Treatment Paradigm: Selecting Patients for Surgical Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Nevarez NM; Yopp AC
J Hepatocell Carcinoma; 2021; 8():851-860. PubMed ID: 34350140
[TBL] [Abstract][Full Text] [Related]
22. Surgical outcome and risk scoring to predict survival after hepatic resection for hepatocellular carcinoma with portal vein tumor thrombosis.
Kim TS; Yang K; Choi GH; Yang HY; Kim DS; Jo HS; Choi GS; Kim KW; Yoon YC; Han J; Kim DJ; Hwang S; Kang KJ
Ann Hepatobiliary Pancreat Surg; 2024 May; 28(2):134-143. PubMed ID: 38720612
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis.
Chen JS; Wang Q; Chen XL; Huang XH; Liang LJ; Lei J; Huang JQ; Li DM; Cheng ZX
J Surg Res; 2012 Jun; 175(2):243-50. PubMed ID: 21601221
[TBL] [Abstract][Full Text] [Related]
24. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
Mähringer-Kunz A; Steinle V; Düber C; Weinmann A; Koch S; Schmidtmann I; Schotten S; Hinrichs JB; Graafen D; Pinto Dos Santos D; Galle PR; Kloeckner R
Liver Int; 2019 Feb; 39(2):324-331. PubMed ID: 30318826
[TBL] [Abstract][Full Text] [Related]
25. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY
Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112
[TBL] [Abstract][Full Text] [Related]
26. Comparison of three-dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus.
Su F; Chen KH; Liang ZG; Wu CH; Li L; Qu S; Chen L; Zhu XD; Zhong JH; Li LQ; Xiang BD
Cancer Med; 2018 Sep; 7(9):4387-4395. PubMed ID: 30062844
[TBL] [Abstract][Full Text] [Related]
27. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
Zhang XP; Wang K; Li N; Zhong CQ; Wei XB; Cheng YQ; Gao YZ; Wang H; Cheng SQ
BMC Cancer; 2017 Dec; 17(1):902. PubMed ID: 29282010
[TBL] [Abstract][Full Text] [Related]
28. Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study.
Chen ZH; Zhang XP; Lu YG; Li LQ; Chen MS; Wen TF; Jia WD; Zhou D; Li J; Yang DH; Zhen ZJ; Xia YJ; Fan RF; Huang YQ; Zhang Y; Wu XJ; Hu YR; Tang YF; Lin JH; Zhang F; Zhong CQ; Guo WX; Shi J; Lau J; Cheng SQ
Hepatol Int; 2020 Sep; 14(5):754-764. PubMed ID: 32253678
[TBL] [Abstract][Full Text] [Related]
29. Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus.
Zheng N; Wei X; Zhang D; Chai W; Che M; Wang J; Du B
Medicine (Baltimore); 2016 Jun; 95(26):e3959. PubMed ID: 27367992
[TBL] [Abstract][Full Text] [Related]
30. Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis.
Shaohua L; Qiaoxuan W; Peng S; Qing L; Zhongyuan Y; Ming S; Wei W; Rongping G
PLoS One; 2015; 10(6):e0130021. PubMed ID: 26076461
[TBL] [Abstract][Full Text] [Related]
31. Case Report: Combining liver partition and portal vein ligation after thrombectomy for tumor isolation (CLAPT) to treat advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Jin Z; Wu G; Xu B; Wang J; Zhu H; Guo Y; Peng M; Peng T; Wen Z
Front Surg; 2022; 9():928452. PubMed ID: 36176342
[TBL] [Abstract][Full Text] [Related]
32. A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus.
Liang L; Chen TH; Li C; Xing H; Han J; Wang MD; Zhang H; Lau WY; Wu MC; Shen F; Yang T
HPB (Oxford); 2018 Dec; 20(12):1119-1129. PubMed ID: 30056066
[TBL] [Abstract][Full Text] [Related]
33. The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study.
Mähringer-Kunz A; Steinle V; Kloeckner R; Schotten S; Hahn F; Schmidtmann I; Hinrichs JB; Düber C; Galle PR; Lang H; Weinmann A
PLoS One; 2021; 16(5):e0249426. PubMed ID: 33961627
[TBL] [Abstract][Full Text] [Related]
34. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
Cheng S; Chen M; Cai J;
Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
[TBL] [Abstract][Full Text] [Related]
35. A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis.
Jia Z; Jiang G; Tian F; Zhu C; Qin X
Saudi J Gastroenterol; 2016; 22(5):353-359. PubMed ID: 27748320
[TBL] [Abstract][Full Text] [Related]
36. Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Yuan G; Cheng X; Li Q; Zang M; Huang W; Fan W; Wu T; Ruan J; Dai W; Yu W; Chen M; Guo Y; Hu X; Chen J
Onco Targets Ther; 2020; 13():12683-12693. PubMed ID: 33328740
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis.
Gao Y; Wang PX; Cheng JW; Sun YF; Hu B; Guo W; Zhou KQ; Yin Y; Li YC; Wang J; Huang JF; Qiu SJ; Zhou J; Fan J; Yang XR
Cancer Med; 2019 Nov; 8(16):6933-6944. PubMed ID: 31566899
[TBL] [Abstract][Full Text] [Related]
38. A case of advanced HCC treated with lenvatinib after hepatic arterial infusion chemotherapy combined with radiation therapy treatment for portal vein tumor thrombosis in the main trunk.
Kosaka Y; Kawaoka T; Aikata H; Suehiro Y; Yamaoka K; Ando Y; Namba M; Takeuchi Y; Fujii Y; Uchikawa S; Kodama K; Oya K; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Imamura M; Baba Y; Awai K; Kimura T; Nagata Y; Chayama K
Clin J Gastroenterol; 2020 Oct; 13(5):839-843. PubMed ID: 31974811
[TBL] [Abstract][Full Text] [Related]
39. Hepatic arterial infusion of oxaliplatin plus raltitrexed in unresectable hepatocellular carcinoma with or without portal vein tumour thrombosis.
Chen S; Yu W; Zhang K; Liu W; Wang X; Chen C
Gastroenterol Rep (Oxf); 2022; 10():goac016. PubMed ID: 35582475
[TBL] [Abstract][Full Text] [Related]
40. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
